Medical Conference Showcases Future Technologies
Complete the form below to unlock access to ALL audio articles.
Nanomed, the nanotechnology in medicine conference taking place in Newcastle upon Tyne at the Civic Centre, has announced backing from a number of commercial companies that will encourage delegates to develop skills and knowledge into business practice.
The conference, taking place on June 27 and 28, focuses on progress in nanoscale science and the value within healthcare applications.
Now in the second year of the conference, regional centres of excellence and international commercial companies are supporting the leading edge conference through sponsorship.
For the second year running Centre of Excellence for Nanotechnology, Micro and Photonic Systems (Cenamps) is partner sponsor of the conference.
Further support comes from the Centre of Excellence for Life Sciences (CELS), Newcastle City Council - City Technology Office, Leeds based law firm Harrison Goddard Foote and the newly formed technology company based in Spain, Nanogap. The Institute of Nanotechnology are also endorsing the event.
The varied programme of the conference focuses on nano-technology and an ageing population.
Topics also include diagnostic and imaging techniques and how nano science will benefit these areas.
The topics aim to provoke debate and discussion amongst delegates as well as creating a platform from which delegates can learn more about this fast progressing field of science.
This year, partner sponsor, Cenamps will run a session entitled Nanotechnology for the Healthcare Market.
CELS are organising and sponsoring the commercialisation of new technologies session.
To accompany the support and key topics, a further commercial session has been added to the programme since 2005.
The Angels’ Den, which has a similar format to the BBC show ‘Dragons’ Den’, provides entrants with the opportunity to pitch nano science business ideas to a panel of judges.
The panel of judges, which be facilitated by Dr Amanda McMurray, commercialisation manager at Cenamps, includes three leading voices in the commercialisation and investment world.
The line up to impress is made up of Dr Alex Buchan, Investment Manager at NorthStar Equity Investors, Duncan Lowery, fund manager at NEL Fund Managers Limited and Jerel Whittingham, managing director of Amphion Innovations UK Ltd.
The champion of Angels’ Den will go on to win a ‘money-can’t-buy’ prize package.
The Chair of the programme committee, Professor Andrew McCaskie, University of Newcastle upon Tyne, says, "Although at an early stage, it is hoped that nanomedicine will provide novel treatment options for a wide variety of diseases."
"I am therefore particularly pleased that the region’s involvement in nanomedicine can be showcased at the Nanomed conference."
"Building on other initiatives like Science City and with a strong programme and new sponsors adding to the support this year, we are looking forward to an even more successful event than 2005."
Dr David Robbins, Chief Technology Officer for Cenamps said, "Nanomed provides a great opportunity for scientists and business people to hear about exciting nanoscience research and about the experiences of different companies in taking nanotechnologies into the healthcare market."
"Any young scientists who aim to turn their research into a business will learn a lot from the advice and support that our expert panel will be giving to budding entrepreneurs in the Angels’ Den session."
